Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Social and geographical factors affecting access to treatment of lung cancer
British Journal of Cancer, 08/20/09
Crawford SM et al. – Living in a deprived locality reduces the likelihood of undergoing definitive management for lung cancer with the exception of chemotherapy for SCLC. This is amplified by travel time to services.
SM Crawford, 08/26/09
| This study was conducted in the context of the UK National Health Service. This means that there was no charge to any of the patients in having diagnostic tests or treatment. Nevertheless there was a consistent disadvantage to patients who live in poorer areas in gaining access. We believe that this disadvantage exerts its effects on events before the patient comes to the attention of a specialist. So, the concern is greatest for residents of deprived areas who live at greatest distances from the relevant healthcare facility. |
Related Articles
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 73%
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Relevance Score: 72%
Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Cancer Research, 10/06/09
Relevance Score: 71%
Noninvasive detection of lung cancer by analysis of exhaled breath
BMC Cancer, 10/09/09
Relevance Score: 70%
African American lung cancer patients may have different response to new cancer-fighting drugs
EurekAlert, 10/08/09
Relevance Score: 70%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiofrequency ablation in the treatment of liver and lung tumors
Bulletin du Cancer, 12/01/09
E7080, a Multi–Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production Profiles
Clinical Cancer Research, 12/01/09
Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer
Cancer Chemotherapy and Pharmacology, 12/01/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


